Antinociceptive activity of vigabatrin in mice

Saudi Pharmaceutical Journal

Volumn 8, Issue 4, 2000, Pages 164-174

  Raza, M ^a   Al Shabanah, O A ^a   Al Harbi, M M ^a   El Hadiyah, T M H ^a   Qureshi, S ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antinociception; Bicuculline; GABA; Locomotion; Naloxone; Vigabatrin

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; BICUCULLINE; NALOXONE; PICROTOXIN; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; BODY TEMPERATURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HYPERALGESIA; LOCOMOTION; MOUSE; NONHUMAN; RECTUM TEMPERATURE;

EID: 0034450348     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Blockade of epileptic responses in the photosensitive baboon, Papio papio, by two irreversible inhibitors of GABA transaminase, γ-acetylenic GABA (4-amino-hex-5-ynoic acid) and γ-vinyl GABA (4-amino-hex-5-enoic acid)
2. Pharmacology and clinical pharmacology of vigabatrin
3. The pharmacology of enzyme-activated inhibition of GABA-transaminase
4. γ-vinyl-GABA: A single blind trial in patients with epilepsy
5. A double blind study of a new drug, γ-vinyl-GABA in patients with refractory epilepsy
6. The action of γ-vinyl-GABA and γ-acetylenic-GABA on the resting and stimulated release of GABA in vivo
7. Effects of anticonvulsants on the in vivo and in vitro release of GABA
8. Effects of valporate, vigabatrin and aminooxyacetic acid on release of endogenous and exogenous GABA from cultured neurons
9. Increased gamma-aminobutyric acid (GABA), homocarnosine, and β-alanine in cerebrospinal fluid of patients treated with γ-vinyl GABA (4-amino-hex-5-enoic acid)
10. Cerebrospinal GABA as an index of brain GABA activity
11. Biochemical and clinical effects of γ-vinyl GABA in patients with epilepsy
12. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model
13. The relationship between GABA concentration in brain and cerebrospinal fluid
14. The effect of 4-amino-hex-5-enoic acid (γ-acetylenic GABA; γ-ethylenic GABA) a catalytic inhibitor of GABA-transaminase in brain metabolism in vivo
15. Increased CSF γ-aminobutyric acid after treatment with γ-vinyl GABA
16. γ-aminobutyric acid and analgesia
17. Valproate and mania
18. GABA and Huntington's Chorea
19. Basal ganglia disease
20. Sodium valproate in the treatment of Nelson's syndrome
21. Huntington's Chorea. Changes in neurotransmitter receptors in the brain
22. Gamma-aminobutyric acid and search for a new anticonvulsant drug
23. An hypothesis suggesting that there is a defect in GABA system in schizophrenia
24. Irreversible inhibitors of GABA transaminase induce antinociceptive effects and potentiate morphine
25. γ-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: Effect on brain metabolism in mice
26. Audiogenic seizure protection by elevated brian GABA concentration in mice: Effects of γ-acetylenic GABA and γ-vinyl GABA, two irreversible GABA-T inhibitors
27. Naloxone reduces diuretic responses induced by water, alcohol or congenital lack of vasopressin in rats
28. Potentiating effect of morphine upon d-methamphitamine-induced hyperthermia in mice. Effects on naloxone and haloperidol
29. Study of antinociceptive activity of sodium valproate in mice
30. GABAergic influence on defensive fighting in rats
31. Naloxone is a GABA antagonist: Evidence from iontophoretic, receptor binding and convulsant studies
32. Involvement of GABA in the antinociceptive effects of gamma-acetylenic GABA (GAG), an inhibitor of GABA-transaminase
33. Determination of R(-) and S(+)-enantiomers of γ-vinyl-γ-aminobutyric acid in human body fluids by gas-chromatography-mass spectrometry
34. Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer
35. On the mechanism of action of sodium valproate. The relationship of GABA and cyclic GMP levels to anticonvulsant activity
36. In vivo effects of aminooxyacetic acid and valproate on nerve terminals (synaptosomal) GABA levels in discrete brain areas in rat
37. GABA in epilepsy. The pharmacological basis
38. Central analgesic effect of valproate in patients with epilepsy
39. Antinociceptive action of sodium valproate in the mouse
40. GABA-ergic agents-induced antinociceptive effects in mice
41. A-ergic transmission in the hypothalamus of the cat: Behavioral and neurochemical study
42. Presynaptic γ-aminobutyric acid receptors in the rat anococcygeus muscle and their antagonism by 5-aminovaleric acid
43. Baclofen, a selective antagonist for a novel type of GABA-receptor
44. Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals
45. (-)-Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor
46. On the involvement of GABA in the analgesia produced by baclofen, muscimol and morphine
47. A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen
48. Comparison of the antinociceptive effect of γ-aminobutyric acid (GABA) agonists: Evidence for a cholinergic involvement
49. Caffeine reduced locomotor activity: Possible involvement of GABA-ergic-dopaminergic-adenosinergic interaction